Hillary Andrews serves as the Director, Regulatory and Research Partnerships at Friends of Cancer Research (Friends). Friends is an advocacy organization based in Washington, DC that drives collaboration among partners from every healthcare sector to power advances in science, policy, and regulation that speed life-saving treatments to patients.
Hillary supports the development and implementation of the organization’s research and policy agenda. She uses her scientific and advocacy background to develop evidence-based policies. Hillary collaborates with diverse teams to identify challenges in cancer research and create solutions that improve and accelerate cancer care for patients.
Prior to joining Friends, Hillary worked as a consultant at Avalere Health where she supported clients in navigating the regulatory strategy and FDA policy environment to improve market access. Hillary also provided clinical and scientific expertise to develop data driven research projects using Medicare and commercial claims data.
Hillary works with Theresa’s Research Foundation to improve cancer research through establishing relationships between cancer researchers and patient advocates. She has discussed this work in podcasts, webinars, and a TEDx. Hillary also worked as an Elevate Ambassador with the National Coalition for Cancer Survivorship to build programs to achieve this goal.
Hillary completed a postdoctoral fellowship in tumor biology at Georgetown University’s Lombardi Comprehensive Cancer Center. She received her PhD in endocrinology and animal biosciences from Rutgers University and her BS in behavioral neuroscience from Lehigh University.
